HUABAO INT.HLG.ADR50/-,10 ADR

View in Terminal

1M6MYTD1Y5YMAX

Loading quotes...

Chart analytics

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, HUABAO INT.HLG.ADR50/-,10 ADR has already paid €0.31 in dividends. The last payout was in July.

Financials

In the last quarter, HUABAO INT.HLG.ADR50/-,10 ADR had revenue of €239.55m and net profit of €13.3m

(EUR)	June 2026	YoY
Revenue	239.55m	-
Gross profit	96.34m	-
Net profit	13.3m	-
EBITDA	33.89m	-

Fundamentals

Metric	Value
Market capitalization	€1.42bn
Number of shares	64.57m
52-week high/low	€21.95 - €12.82
Dividend yield	2.69%
Dividends TTM	€0.55
Beta	-0.07
P/E ratio	-23.19
PEG ratio	0.67
P/B ratio	0.85
P/S ratio	2.58

Company profile

Zhejiang East Asia Pharmaceutical Co., Ltd. beschäftigt sich mit der Herstellung und dem Vertrieb von aktiven pharmazeutischen Wirkstoffen (API), Tabletten, Granulaten und Kapseln. Das Unternehmen wurde 1992 gegründet und hat seinen Hauptsitz in Taizhou, China.